Zymeworks Competitors and Similar CompaniesClear all
Zymeworks's competitors and similar companies include Foghorn Therapeutics.
 Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2003 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Vancouver, CA HQ Seattle, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 45519% increase | Employees 16135% increase |
Valuation ($) | Valuation ($) 973.3 m | Valuation ($) 452 m |
Financial | ||
Revenue (est.) | Revenue (est.) $76m (FY, 2023) | Revenue (est.) $34.2m (FY, 2023) |
Net income | Net income ($118.7m) (FY, 2023) | Net income ($98.4m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 125.9m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
161↑ 35% increase
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company